4dz3
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | [[Image:4dz3.jpg|left|200px]] | ||
| - | |||
| - | <!-- | ||
| - | The line below this paragraph, containing "STRUCTURE_4dz3", creates the "Structure Box" on the page. | ||
| - | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
| - | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
| - | or leave the SCENE parameter empty for the default display. | ||
| - | --> | ||
{{STRUCTURE_4dz3| PDB=4dz3 | SCENE= }} | {{STRUCTURE_4dz3| PDB=4dz3 | SCENE= }} | ||
| - | |||
===Crystal structure of a Peptidyl-prolyl cis-trans isomerase with surface mutation M61H from Burkholderia pseudomallei complexed with FK506=== | ===Crystal structure of a Peptidyl-prolyl cis-trans isomerase with surface mutation M61H from Burkholderia pseudomallei complexed with FK506=== | ||
| + | {{ABSTRACT_PUBMED_24366729}} | ||
| + | ==About this Structure== | ||
| + | [[4dz3]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Burp1 Burp1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4DZ3 OCA]. | ||
| - | == | + | ==Reference== |
| - | + | <ref group="xtra">PMID:024366729</ref><references group="xtra"/><references/> | |
| - | [[Category: | + | [[Category: Burp1]] |
[[Category: Peptidylprolyl isomerase]] | [[Category: Peptidylprolyl isomerase]] | ||
[[Category: SSGCID, Seattle Structural Genomics Center for Infectious Disease.]] | [[Category: SSGCID, Seattle Structural Genomics Center for Infectious Disease.]] | ||
Revision as of 13:32, 12 March 2014
Crystal structure of a Peptidyl-prolyl cis-trans isomerase with surface mutation M61H from Burkholderia pseudomallei complexed with FK506
Template:ABSTRACT PUBMED 24366729
About this Structure
4dz3 is a 2 chain structure with sequence from Burp1. Full crystallographic information is available from OCA.
Reference
- Begley DW, Fox D 3rd, Jenner D, Juli C, Pierce PG, Abendroth J, Muruthi M, Safford K, Anderson V, Atkins K, Barnes SR, Moen SO, Raymond AC, Stacy R, Myler PJ, Staker BL, Harmer NJ, Norville IH, Holzgrabe U, Sarkar-Tyson M, Edwards TE, Lorimer DD. A structural biology approach enables the development of antimicrobials targeting bacterial immunophilins. Antimicrob Agents Chemother. 2014 Mar;58(3):1458-67. doi: 10.1128/AAC.01875-13., Epub 2013 Dec 23. PMID:24366729 doi:http://dx.doi.org/10.1128/AAC.01875-13
